home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

A Great Warm-up Act

  August, 7 2008 17:35
your information resource in human molecular genetics

Promoting blood vessel growth and tissue remodelling may improve outcome in patients with muscular dystrophy, according to a study published online in Nature Medicine. This idea could help extend new cell based therapies to individuals with the disease who are currently untreatable.

Reduced number and increased stiffness of blood vessels characterize advanced stages of Duchenne muscular dystrophy, often preventing treatment. Giulio Cossu and colleagues modified tendon fibroblasts to express PlGF, a molecule that promotes blood vessel growth, and MMP-9, a molecule important for tissue remodelling. Injecting these modified cells in the muscle of old, dystrophic mice, they restored the vascular network and reduced collagen deposition.

Subsequent therapy with mesangioblasts, cells that need to integrate into the muscle to promote its recovery, worked better in mice that received the 'preparatory' injection, as the treated muscles were more receptive to the mesangioblasts.

Author contact:

Giulio Cossu (H. San Raffaele, Milan, Italy)
E-mail: cossu.giulio@hsr.it

Abstract available online.

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.